Résonance magnétique cardiaque (RMC) c’est une technique sans rayonnement, qui est considérée comme l’étalon-or pour l’évaluation de l’anatomie cardiaque, de la fonction et même de la composition des tissus. L’essai RESILIENCE utilisera la RMC comme principale méthodologie de mesure des résultats, et les patients inscrits à l’essai subiront 3 examens pendant toute la durée de l’étude.
Essai clinique multinational, prospectif, de preuve de concept de phase II, à double insu, contrôlé par simulation, randomisé (ECR) pour évaluer l’efficacité et l’innocuité du préconditionnement ischémique distal (RIC) chez les patients atteints de Lymphome recevant des anthracyclines. Les patients devant subir ≥5 cycles de chimiothérapie seront éligibles.
Newsletter N.10, June 2024 This Project has received funding from the European Union´s Horizon 2020 research and innovation programme under grant agreement No 945118 Evolution of RESILIENCE We continue working for the growth of the project because for us every patient counts ❤ Interviews Dr. Maria Gomes Da Silva https://youtu.be/3G_E0IoXhFg?si=fVCxWzNVJ9bIfvUA
In the framework of the European Researchers’ Night and the Science and Innovation Week to be celebrated in Madrid on September and November, our team RESILIENCE has planned two activities open to public of all ages upon registration. There will be two workshops and roundtables under the title “RESILIENCE: Survive
Since we started the RESILIENCE project, we have held regular encounters with our patients, and family members who wish to attend, along with members of our team. We believe these gatherings are a fruitful experience in which they have the chance of sharing their needs with us so we may
Due to the commemoration of the European Day for the Prevention of Cardiovascular Risk on March 14th we have launched a campaign on our Instagram to collect your questions and concerns about this topic. Doctor Alberto López, member of our RESILIENCE team, have answered them. Dr. López is an expert
It is a great satisfaction for us to announce the incorporation of the Amsterdam UMC Hospital to the RESILIENCE project on November 8th. Amsterdam UMC is one of the largest academic hospitals in the Netherlands and consists of 2 centers: The Amsterdam UMC located at the AMC (Academic Medical Center)
On October 23rd, Puerta de Hierro Majadahonda University Hospital joined the RESILIENCE project, so hopefully it will begin to incorporate patients into the trial in the coming days. This hospital was created in 1964 and, since then, it has fulfilled a triple function: care, teaching and research. Currently, as a
